Search
Returning search results with filters:
Remove filter for
Type: Health professional risk communication
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 2 of 2 items.
… room (ER) physicians. Key messages On June 9, 2021, casirivimab and imdevimab, two monoclonal antibodies, were authorized for use … and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered together, are …
AlertHealth professional risk communication | 2021-07-30
… Last updated 2022-01-07 Summary Product Casirivimab and Imdevimab Issue Health products - New safety information … below Audience Health professionals Affected products Casirivimab and imdevimab concentrate for infusion is …
AlertHealth professional risk communication | 2022-01-07